BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10738351)

  • 21. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS).
    Booth J; Clayton T; Pepper J; Nugara F; Flather M; Sigwart U; Stables RH;
    Circulation; 2008 Jul; 118(4):381-8. PubMed ID: 18606919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).
    Rodriguez AE; Baldi J; Fernández Pereira C; Navia J; Rodriguez Alemparte M; Delacasa A; Vigo F; Vogel D; O'Neill W; Palacios IF;
    J Am Coll Cardiol; 2005 Aug; 46(4):582-8. PubMed ID: 16098419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of native coronary artery disease progression following PTCA or CABG in the Emory Angioplasty Versus Surgery Trial.
    Zhao XQ; Kosinski AS; Barnhart HX; Superko HR; King SB
    Med Sci Monit; 2003 Feb; 9(2):CR48-54. PubMed ID: 12601286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical outcome after coronary bypass surgery: a 30-year follow-up study.
    van Domburg RT; Kappetein AP; Bogers AJ
    Eur Heart J; 2009 Feb; 30(4):453-8. PubMed ID: 19066209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery.
    Brener SJ; Lytle BW; Casserly IP; Ellis SG; Topol EJ; Lauer MS
    Eur Heart J; 2006 Feb; 27(4):413-8. PubMed ID: 16272211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late outcome after stenting or coronary artery bypass surgery for the treatment of multivessel disease: a single-center matched-propensity controlled cohort study.
    van Domburg RT; Takkenberg JJ; Noordzij LJ; Saia F; van Herwerden LA; Serruys PW; Bogers AJ
    Ann Thorac Surg; 2005 May; 79(5):1563-9. PubMed ID: 15854934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 13-year follow-up of the German angioplasty bypass surgery investigation.
    Kaehler J; Koester R; Billmann W; Schroeder C; Rupprecht HJ; Ischinger T; Jahns R; Vogt A; Lampen M; Hoffmann R; Riessen R; Berger J; Meinertz T; Hamm CW
    Eur Heart J; 2005 Oct; 26(20):2148-53. PubMed ID: 15975991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
    Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored approach based on coronary pressure measurement.
    Botman KJ; Pijls NH; Bech JW; Aarnoudse W; Peels K; van Straten B; Penn O; Michels HR; Bonnier H; Koolen JJ
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):184-91. PubMed ID: 15390344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II?
    Gruberg L; Mercado N; Milo S; Boersma E; Disco C; van Es GA; Lemos PA; Ben Tzvi M; Wijns W; Unger F; Beyar R; Serruys PW;
    Am J Cardiol; 2005 Feb; 95(4):439-44. PubMed ID: 15695125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival in patients with peripheral vascular disease after percutaneous coronary intervention and coronary artery bypass graft surgery.
    O'Rourke DJ; Quinton HB; Piper W; Hernandez F; Morton J; Hettleman B; Hearne M; Nugent W; O'Connor GT; Malenka DJ;
    Ann Thorac Surg; 2004 Aug; 78(2):466-70; discussion 470. PubMed ID: 15276497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of multivessel coronary artery disease on outcome after isolated minimally invasive bypass grafting of the left anterior descending artery.
    Lichtenberg A; Klima U; Paeschke H; Pichlmaier M; Ringes-Lichtenberg S; Walles T; Goerler H; Haverich A
    Ann Thorac Surg; 2004 Aug; 78(2):487-91. PubMed ID: 15276503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Coronary angioplasty in elderly patients].
    Liistro F; Colombo A
    Ital Heart J Suppl; 2002 Jan; 3(1):1-8. PubMed ID: 11899566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Abbott JD; Voss MR; Nakamura M; Cohen HA; Selzer F; Kip KE; Vlachos HA; Wilensky RL; Williams DO
    J Am Coll Cardiol; 2007 Nov; 50(21):2029-36. PubMed ID: 18021868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.
    Kirtane AJ; Ellis SG; Dawkins KD; Colombo A; Grube E; Popma JJ; Fahy M; Leon MB; Moses JW; Mehran R; Stone GW
    J Am Coll Cardiol; 2008 Feb; 51(7):708-15. PubMed ID: 18279734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term prognosis in patients with single-vessel or double-vessel coronary artery disease: does successful revascularization achieved by coronary angioplasty improve late outcome?].
    Kawaharada T
    J Cardiol; 2003 Jul; 42(1):1-11. PubMed ID: 12892036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Percutaneous transluminal coronary angioplasty in 1980-85 and 1995-96: more frequent multivessel disease, fewer reoperations and no change in mortality 1 and 5 years postoperatively].
    van Domburg RT; Vos J; Serruys PW
    Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2196-200. PubMed ID: 12467164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design.
    Kapur A; Malik IS; Bagger JP; Anderson JR; Kooner JS; Thomas M; Punjabi P; Mayet J; Millane T; Goedicke J; Jamrozik K; de Belder MA; Hall RJ; Beatt KJ
    Am Heart J; 2005 Jan; 149(1):13-9. PubMed ID: 15660030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of performing a clinical trial on patient outcomes: lessons from the Emory Angioplasty vs. Surgery Trial.
    King SB
    Trans Am Clin Climatol Assoc; 1996; 107():68-77; discussion 77-8. PubMed ID: 8725561
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.